Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)-Reference-Cited by-同舟云学术

Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)

Published:2009-12 Issue:2-3 Volume:115 Page:97-103
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Boter Han,Peuskens Joseph,Libiger Jan,Fleischhacker W. Wolfgang,Davidson Michael,Galderisi Silvana,Kahn René S.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference18 articles.

1. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am. J. Psychiatry,2005

2. Remission in first-episode psychosis: predictor variables and symptom improvement patterns;Emsley;J. Clin. Psychiatry,2006

3. Time course for antipsychotic treatment response in first-episode schizophrenia;Emsley;Am. J. Psychiatry,2006

4. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates;Emsley;Schizophr. Res.,2007

5. Risperidone in the treatment of first episode psychotic patients: a double-blind multicenter study. Risperidone Working Group;Emsley;Schizophr. Bull.,1999

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study;Schizophrenia Research;2024-08

2. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders;Cochrane Database of Systematic Reviews;2024-07-03

3. Pharmacological Therapy;Psychiatric Intensive Care;2024-03-28

4. Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia;Expert Opinion on Drug Safety;2024-03-25

5. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024